Cell signaling

Aviptadil

VIP / Vasoactive intestinal peptide / RLF-100

Peptide length
28 amino acids

Synthetic VIP peptide

Research contextHuman studies exist

Read the linked studies for their methods and limitations.

A synthetic form of vasoactive intestinal peptide studied in respiratory and other clinical settings.

Family
Vasoactive intestinal peptide
Research frame
VIP receptors
Molecular format
Synthetic VIP peptide

Read the evidence

The randomized TESICO COVID-19 trial did not show a significant improvement in clinical outcomes with aviptadil. Earlier signals must be read alongside that result.

Resolve the identity

Keep standalone aviptadil, combination products and route-specific formulations separate.